NIH-funded research R21 grant

N-acetylserotonin helps reduce alcohol misuse after brain injuries.

Official title: N-acetylserotonin alleviates neurotoxicity in alcohol misuse following TBI

Funded at Brigham and Women's Hospital · NIH-10834197 · Data updated 2026-11-12

This study is looking at how a substance called N-acetylserotonin (NAS) might help people who have had a traumatic brain injury and are dealing with alcohol use problems, by exploring how it could reduce their alcohol cravings and improve their recovery.

More Alcohol Misuse research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionBrigham and Women's Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startMay 1, 2023
Project endApril 30, 2026
Funding year2024
Award (this year)$190,461
NIH project number5R21AA030087-02
Project IDNIH-10834197 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults over 21 years old who have experienced a traumatic brain injury and have a history of alcohol use disorder.

Less likely to help

Patients who do not have a history of alcohol use disorder or have not experienced a traumatic brain injury may not benefit from this research.

What this research studies

This research investigates how N-acetylserotonin (NAS) can help individuals who have experienced traumatic brain injury (TBI) and struggle with alcohol use disorder (AUD). The study aims to understand the molecular mechanisms behind increased alcohol consumption following TBI and to explore NAS as a potential treatment. By examining how NAS interacts with specific brain pathways and reduces neurotoxicity, the research seeks to develop a novel therapy that could improve outcomes for affected patients. Participants may be involved in assessments to evaluate the effectiveness of NAS in reducing alcohol intake and preference.

Why it matters

Potential benefit: If successful, this research could provide a new therapeutic option for individuals dealing with alcohol misuse after a traumatic brain injury.

How similar studies have gone: Previous research has shown that N-acetylserotonin can protect against neurotoxicity in various models, suggesting potential for success in this novel application.

Where this research is happening

  • Brigham and Women's Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Wang, Xin — Brigham and Women's Hospital
  • Study coordinator: Wang, Xin

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.